TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization

TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization

The aim of this study was to evaluate associations between TP53 status and outcomes after transarterial embolization (TAE) for the treatment of patients with hepatocellular carcinoma (HCC). This single-institution study included patients from 1/2014 to 6/2022 who underwent TAE of HCC and genomic ana...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ken Zhao, Anita Karimi, Luke Kelly, Elena Petre, Brett Marinelli, Erica S. Alexander, Vlasios S. Sotirchos, Joseph P. Erinjeri, Anne Covey, Constantinos T. Sofocleous, James J. Harding, William Jarnagin, Carlie Sigel, Efsevia Vakiani, Etay Ziv, Hooman Yarmohammadi
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Current Oncology
Subjects:	hepatocellular carcinoma interventional oncology transarterial embolization tumor protein p53
Online Access:	https://www.mdpi.com/1718-7729/32/1/51
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Outcome of Superselective Transarterial Embolization for Acute Colonic Gastrointestinal Bleeding: A Retrospective Single-Center Experience
by: Rajendra Kumar Behera, et al.

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Conventional and drug‑eluting bead transarterial chemoembolization in patients with inoperable intrahepatic cholangiocarcinoma: a meta‑analysis
by: Su-Rong Pan, et al.
Published: (2024-11-01)

Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01)

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study
by: Qinxue Sun, et al.
Published: (2025-01-01)

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
by: Lingzhan Meng, et al.
Published: (2024-11-01)

Risk Factors for Postoperative Nausea and Vomiting After TACE: A Prospective Cohort Study
by: Yuzhu Wang, et al.
Published: (2024-12-01)

Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study
by: Hongjie Cai, et al.
Published: (2025-02-01)

A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
by: Wu L, et al.
Published: (2025-01-01)

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla
by: Vlasios S. Sotirchos, et al.
Published: (2014-01-01)

The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma
by: Wu Y, et al.
Published: (2025-02-01)

Kin Competition Drives the Evolution of Earlier Metamorphosis
by: Bing Dong, et al.
Published: (2025-01-01)

Immune Checkpoint Blockade in Melanoma – Earlier is Better?
by: Vincas Urbonas, et al.
Published: (2024-09-01)

Earlier Intervention with Deep Brain Stimulation for Parkinson’s Disease
by: Gerson Suarez-Cedeno, et al.
Published: (2017-01-01)

For Better or Worse: The Effect of Prismatic Adaptation on Auditory Neglect
by: Isabel Tissieres, et al.
Published: (2017-01-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Case report: Transarterial chemoembolization for nasal hemangiosarcoma in a dog
by: Keunho Kim, et al.
Published: (2025-01-01)

Vision of objects happens faster and earlier for location than for identity
by: Christian H. Poth, et al.
Published: (2025-02-01)

COVID-19 – if the cure is worse than the disease. The Italian chaos
by: Giuseppe FERRARI
Published: (2020-03-01)

Antibiotic Prophylaxis in Transarterial Therapy of Hepatocellular Carcinoma: A Meta-Analysis
by: Jun Wang, et al.
Published: (2012-01-01)

Women are worse off in developing and recovering from temporomandibular disorder symptoms
by: Anna Lövgren, et al.
Published: (2025-02-01)

Macular Changes in a Mucopolysaccharidosis Type I Patient with Earlier Systemic Therapies
by: Augusto Magalhães, et al.
Published: (2021-01-01)

Prediction of Microcystis Blooms Based on TN:TP Ratio and Lake Origin
by: Yoshimasa Amano, et al.
Published: (2008-01-01)

A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Adriana Toro, et al.
Published: (2015-01-01)

Urban fruit bats give birth earlier in the season compared to rural fruit bats
by: Maya Weinberg, et al.
Published: (2025-01-01)

TAp63γ is the primary isoform of TP63 for tumor suppression but not development
by: Xinbin Chen, et al.
Published: (2025-02-01)

MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis
by: Vishesh Khanna, et al.
Published: (2025-02-01)

The role of aTp-dependent chromatin remodeling factors in chromatin assembly in vivo
by: Iu. A. Il’ina, et al.
Published: (2019-03-01)

A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
by: Bohao Zhang, et al.
Published: (2025-01-01)

Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin
by: Anna Ugalde, et al.
Published: (2025-01-01)

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
by: Yunzhen Qian, et al.
Published: (2022-01-01)

A Lipiodol Pickering Emulsion Stabilized by Iron‐Doped Carbon Nanozymes for Liver Transarterial Chemoembolization
by: Xiancheng Xia, et al.
Published: (2025-02-01)

Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: A. Rebonato, et al.
Published: (2017-01-01)

Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization—A Meta-Analysis
by: Teodor Kapitanov, et al.
Published: (2015-01-01)

Earlier the Patients Entering Into Prenatal Care, Higher the Cesarean Rates: Analysis of 17.035 Cases
by: Pinar Calis, et al.
Published: (2021-04-01)

Acromegaly: Is earlier diagnosis possible? Exploration of a screening algorithm to select high-risk patients
by: Tessa N.A. Slagboom, et al.
Published: (2025-03-01)

The Health-Related Quality of Life of Patients Waiting for Anterior Cruciate Ligament Reconstruction Is Worse Than an Age- and Sex-Matched Population: Increasing Time on Waiting List for Surgery Was Independently Associated with a Worse Quality of Life
by: Siddharth Sripada, et al.
Published: (2022-01-01)

DeepGame-TP: Integrating Dynamic Game Theory and Deep Learning for Trajectory Planning
by: Giovanni Lucente, et al.
Published: (2024-01-01)

Prolonged venous transit is associated with worse neurological recovery in successfully reperfused large vessel strokes
by: Janet Mei, et al.
Published: (2025-01-01)

The Features of Extrahepatic Collateral Arteries Related to Hepatic Artery Occlusion and Benefits in the Transarterial Management of Liver Tumors
by: Lin Yang, et al.
Published: (2013-01-01)